drug regulation

  • Tweet
  • Share
  • +1
  • LinkedIn 0
  • Email
Expert View

For our medicines, nothing beats staying in EU

by George Peretz | 14.12.2018

Medicine regulation is a matter of life and death, and key to UK industries and science. Even Brexiters accept disadvantages of leaving EU.

Analysis

The scramble for London’s EU agencies

by Luke Lythgoe | 01.08.2017

21 countries have placed bids for the EU’s medicines and banking regulators. The winners’ gain will be another Brexit loss for Britain.

EU not denying patients life-saving breast cancer drugs

by Luke Lythgoe | 13.06.2016

Press claims EU red tape keeps cancer-fighting drug from patients. Manufacturer delays and UK’s value for money concerns are bigger hurdles.